MedTrace Logo

NAC Effect on Hox Genes Expressions in RIF

NCT03862586 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-03-05

No results posted yet for this study

Summary

Comparison of the group treated with NAC-supplementation and placebo- administered groups showed elevations in HOXA cluster genes (all members) expression level in endometrium of women with RIF.

Conditions

  • Female Infertility

Interventions

DRUG

N-acetyl cysteine

DRUG

Placebos

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Parvaneh Afsharian, PhD · Royan Institute

  • Ashraf Moini, MD · Royan Institute

  • Seyed Mehdi Kalantar, PhD · Shahid Sadoughi University of Medical Sciences

  • Maryam Shahhoseini, PhD · Royan Institute

  • Vida Mokhtari, MSc · Royan Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2017-05-01
Completion
2017-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03862586 on ClinicalTrials.gov